WallStSmart

Heartbeam Inc (BEAT)vsBrightSpring Health Services, Inc. Common Stock (BTSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BTSG leads profitability with a 1.5% profit margin vs 0.0%. BTSG earns a higher WallStSmart Score of 54/100 (C-).

BEAT

Avoid

16

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 2.8
Piotroski: 1/9Altman Z: -44.35

BTSG

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 3.0Quality: 7.5
Piotroski: 5/9Altman Z: 2.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BEAT.

BTSGSignificantly Overvalued (-78.4%)

Margin of Safety

-78.4%

Fair Value

$22.46

Current Price

$44.82

$22.36 premium

UndervaluedFair: $22.46Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BEAT0 strengths · Avg: 0/10

No standout strengths identified

BTSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
29.3%8/10

Revenue surging 29.3% year-over-year

Areas to Watch

BEAT4 concerns · Avg: 3.8/10
Price/BookValuation
16.0x4/10

Trading at 16.0x book value

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$47.25M3/10

Smaller company, higher risk/reward

BTSG4 concerns · Avg: 3.3/10
EPS GrowthGrowth
3.4%4/10

3.4% earnings growth

Return on EquityProfitability
5.9%3/10

ROE of 5.9% — below average capital efficiency

Profit MarginProfitability
1.5%3/10

1.5% margin — thin

Operating MarginProfitability
3.0%3/10

Operating margin of 3.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : BEAT

BEAT has a balanced fundamental profile.

Bull Case : BTSG

The strongest argument for BTSG centers on Revenue Growth. Revenue growth of 29.3% demonstrates continued momentum.

Bear Case : BEAT

The primary concerns for BEAT are Price/Book, Revenue Growth, EPS Growth.

Bear Case : BTSG

The primary concerns for BTSG are EPS Growth, Return on Equity, Profit Margin. A P/E of 90.2x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

BEAT profiles as a value stock while BTSG is a growth play — different risk/reward profiles.

BTSG carries more volatility with a beta of 2.33 — expect wider price swings.

BTSG is growing revenue faster at 29.3% — sustainability is the question.

BTSG generates stronger free cash flow (174M), providing more financial flexibility.

Bottom Line

BTSG scores higher overall (54/100 vs 16/100) and 29.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Heartbeam Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.

Visit Website →

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.

Visit Website →

Want to dig deeper into these stocks?